Developer docs
API playgroundTry for free, no card

Search company profiles

Subtle Medical

Full company profile

uuid00002r3

Namestring
Subtle Medical
Legal namestring
Subtle Medical, Inc.
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Subtle Medical, Inc. is a Menlo Park, California-based medical imaging AI company founded in 2017 by Stanford researchers Enhao Gong, PhD and Greg Zaharchuk, MD, PhD. The company develops vendor-neutral deep learning software that enhances the quality and efficiency of MRI, PET, and CT imaging across all major scanner manufacturers. Its core technology uses proprietary convolutional neural networks and generative AI models to perform image reconstruction, denoising, synthesis, and harmonization, deployed natively on NVIDIA GPU infrastructure. The product portfolio includes Subtle-ELITE (an integrated MRI package bundling SubtleHD(MR), SubtleSYNTH, and SubtleALIGN), standalone SubtleHD variants for PET and CT, the AiMIFY contrast-enhancement solution developed with Bracco, and R&D-stage products including SubtleGAD (gadolinium-dose reduction with Bayer) and SubtleNG (a vision-language foundation model for MRI metadata harmonization).

The company's primary revenue model is SaaS subscription to hospitals and imaging centers, with pricing aligned to scanner deployments across its installed base of 1,300+ scanners and 600+ US sites imaging 2.5 million patients annually. Secondary revenue streams include OEM licensing royalties (notably with Siemens Healthineers) and pharmaceutical industry co-development partnerships (Bracco for AiMIFY, Bayer for SubtleGAD). The go-to-market is enterprise field sales to hospital systems and radiology groups, supplemented by group purchasing contracts (Strategic Radiology, Vizient) and channel partners (Hospiline in Latin America). The company has secured 11 FDA 510(k) clearances, EU MDR CE Marking, Health Canada, ANVISA, and UK MHRA approvals, plus ISO 13485/MDSAP and ISO/IEC 42001 AI Management System certifications, enabling commercial sales across the US, EU, UK, Canada, Brazil, Chile, China (100+ hospitals), and planned APAC expansion. Following a $33 million Series C led by Morgan Stanley Expansion Capital in June 2026, Subtle Medical had raised approximately $86 million in cumulative capital and brought in industry veteran Ohad Arazi (formerly CEO of Zebra Medical Vision and Clarius, and an 11-year McKesson/Change Healthcare executive) as CEO to lead its next phase of global enterprise expansion.

Short descriptiontext

Subtle Medical develops vendor-neutral AI software that enhances MRI, PET, and CT image quality and accelerates scan times, serving hospitals, imaging centers, and OEM partners across 1,300+ scanner deployments worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical imaging AI, deep learning radiology, MRI image enhancement, PET image acceleration, AI image denoising
Industry4 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code2 codes
  • Software Publishers5132
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging AI Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Subscription to Hospitals and Imaging Centers
TypeSubscription Recurring
Description

Primary revenue stream - Subtle Medical primarily offers AI solutions as SaaS or software systems to hospitals and imaging centers in the United States, Europe, and Latin America. Recurring subscription model aligned with scanner deployments (over 1,300 scanners worldwide).

subtlemedical.com
2OEM Licensing (e.g., Siemens Healthineers)
TypeLicensing Royalties
Description

Subtle Medical is contracted by medical imaging equipment manufacturers such as Siemens Healthineers to embed Subtle's AI solutions and platform, providing licensing royalties for workflow, quality, and efficiency enhancements in MRI and PET imaging.

subtlemedical.com
3Pharmaceutical Industry Partnerships (Bayer, Bracco)
TypeLicensing Royalties
Description

Revenue from co-development agreements with pharmaceutical companies. Bracco's AiMIFY™ is manufactured for Bracco Diagnostics Inc. by Subtle Medical Inc. (OEM/white-label arrangement). Bayer is collaborating on SubtleGAD™ clinical development. These partnerships leverage Subtle's AI solutions for contrast and radiopharmaceutical applications.

subtlemedical.com
Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 9 records shown
1SubtleHD™
Description

AI-powered denoising and sharpening solution for MRI, PET, and CT imaging enhancement, enabling up to 80% faster scan times. Includes SubtleHD(MR), SubtleHD(PET), and SubtleHD(CT) variants.

subtlemedical.com
+8 more records
Core offering1 text field

Subtle Medical develops vendor-neutral deep learning software that enhances medical image quality and accelerates scan times across MRI, PET, and CT modalities. Its products use convolutional neural networks and generative AI to perform denoising, sharpening, synthetic contrast generation, and automated alignment on existing scanners without requiring new hardware. Solutions are deployed on more than 1,300 scanners worldwide, with the flagship Subtle-ELITE package bundling three FDA-cleared MRI tools.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Subtle Medical operates a multi-modality, vendor-neutral AI imaging platform rather than a single unified product, organized around an evolving AI Imaging Hub strategy. The portfolio spans MRI, PET, and CT workflows through distinct AI software products: the Subtle-ELITE package bundles three FDA-cleared MRI tools (SubtleHD(MR) for denoising/sharpening with up to 80% faster scans, SubtleSYNTH for synthetic STIR contrast generation with 100% acceleration, and SubtleALIGN for automated brain MR alignment); standalone products SubtleHD(PET) and SubtleHD(CT) extend the same AI image enhancement paradigm to PET and CT modalities respectively. Legacy products SubtleMR and SubtlePET remain deployed globally, while AiMIFY is a partner-distributed AI contrast enhancement product sold by Bracco. R&D pipeline products include SubtleGAD (reduced gadolinium dose synthesis with Bayer), SubtleREFORMAT (MRI data harmonization), SubtleALLY (workflow automation), and SubtleNG (vision-language foundation model for metadata standardization). Together these products are designed to integrate seamlessly across manufacturer-agnostic scanner fleets, replacing fragmented point solutions with a single AI infrastructure layer for radiology.

Product and service10 records
1Subtle-ELITE
CategoryAI Software Platform / Package Bundle
Description

Industry-first integrated AI-powered MRI package that combines three FDA-cleared software tools — SubtleHD(MR), SubtleSYNTH, and SubtleALIGN — designed to dramatically improve MRI image quality, reduce scan times, and eliminate manual work through deep learning image processing. Targeted at hospitals and imaging centers.

2SubtleHD(MR)
CategoryMRI Imaging AI Software
Description

AI-powered denoising and sharpening software for ultra-clear MRI images, enabling up to 80% faster scan times on some sequences. Vendor-neutral across all body parts, sequences, and contrasts. FDA-cleared and CE-marked. Targeted at radiology departments.

3SubtleSYNTH
CategoryMRI Synthetic Imaging AI
Description

AI-generated MR imaging contrasts that synthesize STIR images from existing T1 and T2 weighted sequences with zero additional acquisition time, achieving 100% acceleration. First FDA-cleared AI solution for synthetic imaging. Targeted at MRI imaging centers.

4SubtleALIGN
CategoryMRI Workflow AI Software
Description

AI-powered automation of brain MR alignment to ideal anatomical position, reducing manual adjustments and improving consistency across longitudinal studies. Supports 3D brain sequences. Part of the Subtle-ELITE package. Targeted at neuroradiology practices.

5SubtleHD(PET)
CategoryPET Imaging AI Software
Description

AI-powered image enhancement software for low-count PET imaging, denoising PET acquisitions across existing PET, PET/CT, and PET/MR scanners. Enables up to 75% faster PET imaging and supports all FDA-approved radiotracers. Targeted at nuclear medicine and PET centers.

6SubtleHD(CT)
CategoryCT Imaging AI Software
Description

AI-powered denoising software for ultra-clear CT images that reduces noise and improves image clarity across different CT scanner generations. Helps healthcare providers enhance imaging quality from existing CT infrastructure without requiring new hardware. Targeted at radiology departments.

7SubtleMR
CategoryLegacy MRI Imaging AI Software
Description

First-to-market AI-powered MRI image enhancement software, FDA 510(k) cleared in October 2019, enabling up to 60% faster MRI acquisition. Now superseded by SubtleHD(MR) but still deployed globally on vendor-neutral MRI scanners.

8SubtlePET
CategoryLegacy PET Imaging AI Software
Description

First FDA-cleared AI-powered PET image enhancement software, enabling faster, lower-dose PET imaging. Now superseded by SubtleHD(PET) but still deployed across numerous PET scanners worldwide. Targeted at PET imaging centers.

9AiMIFY
CategoryPartner AI Contrast Enhancement Software
Description

AI-powered contrast enhancement software for brain MR images, exclusively developed with Bracco using Subtle Medical technology. Selectively amplifies brain lesion visualization for up to double the visibility of FDA-approved gadolinium doses (GBCAs). FDA-cleared as Class II SaMD. Sold by Bracco as the commercial distributor.

10SubtleGAD
CategoryMRI Contrast AI Software (in development)
Description

Investigational AI-powered contrast enhancement technology that synthesizes full-dose contrast-enhanced images from reduced gadolinium doses, with research demonstrating potential for up to 90% gadolinium dose reduction while maintaining diagnostic image quality. In active clinical development with Bayer.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Aidoc provides an AI-powered radiology platform with FDA-cleared algorithms for triage and workflow across CT and MRI. It directly competes with Subtle Medical for enterprise hospital imaging AI contracts and uses a similar SaaS/deployment model across hospital systems.

TypeDirect peer
Description

RapidAI offers AI software for neuroimaging and stroke workflow, with FDA-cleared image analysis across MRI and CT. It shares Subtle Medical's hospital-channel enterprise sales motion and vendor-neutral integration model for radiology AI.

TypeDirect peer
Description

Viz.ai develops AI-powered clinical workflow and image analysis for stroke and other time-sensitive conditions, deployed across hospital networks. It competes with Subtle Medical in the same hospital imaging AI category with FDA-cleared products and similar enterprise sales motion.

TypeDirect peer
Description

Arterys offers a cloud-native AI medical imaging platform with FDA-cleared products for MRI and CT, using deep learning for image quantification and workflow. Its SaaS model, modality focus, and regulatory track record closely mirror Subtle Medical's positioning.

5Zebra Medical Vision (Nanox)
TypeDirect peer
Description

Zebra Medical Vision, now part of Nanox, developed AI imaging algorithms for radiology across multiple modalities and was previously led by Subtle Medical's new CEO Ohad Arazi. It is highly comparable in product strategy and customer base.

TypeBroad incumbent
Description

Siemens Healthineers is both a partner (OEM licensing Subtle's AI) and a competitor through its AI-Rad Companion platform embedded in its MRI and CT scanners. Its installed-base reach and bundled AI strategy represent the largest incumbent threat to Subtle's vendor-neutral model.

TypeBroad incumbent
Description

GE HealthCare's Edison AI platform bundles imaging AI directly into its MRI, CT, and PET scanners, competing with Subtle Medical across hospital accounts. Several Subtle Medical executives (CTO, Head of Clinical) are former GE Healthcare leaders, reflecting the close competitive and talent dynamics.

TypeBroad incumbent
Description

Philips offers AI-enabled imaging solutions across its MRI, CT, and PET/CT installed base and competes broadly with Subtle Medical for hospital imaging AI budget. Subtle Medical's CCO and Head of North America Sales are former Philips executives.

TypeBroad incumbent
Description

Canon Medical's AiCE deep learning reconstruction is embedded in its CT and MRI scanners, directly competing with SubtleHD for acceleration and denoising workloads. As a scanner OEM bundling AI, Canon represents an incumbent channel-conflict risk.

10United Imaging Intelligence
TypeEmerging player
Description

United Imaging Intelligence develops AI applications across its parent company's MRI, CT, and PET scanner lines, with strong presence in China. It overlaps with Subtle Medical's product portfolio and is a relevant emerging competitor especially across APAC.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance14 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds12 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors25 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Subtle Medical

Medical Imaging AI Softwaresubtlemedical.com

Subtle Medical develops vendor-neutral AI software that enhances MRI, PET, and CT image quality and accelerates scan times, serving hospitals, imaging centers, and OEM partners across 1,300+ scanner deployments worldwide.

What Subtle Medical does

Subtle Medical, Inc. is a Menlo Park, California-based medical imaging AI company founded in 2017 by Stanford researchers Enhao Gong, PhD and Greg Zaharchuk, MD, PhD. The company develops vendor-neutral deep learning software that enhances the quality and efficiency of MRI, PET, and CT imaging across all major scanner manufacturers. Its core technology uses proprietary convolutional neural networks and generative AI models to perform image reconstruction, denoising, synthesis, and harmonization, deployed natively on NVIDIA GPU infrastructure. The product portfolio includes Subtle-ELITE (an integrated MRI package bundling SubtleHD(MR), SubtleSYNTH, and SubtleALIGN), standalone SubtleHD variants for PET and CT, the AiMIFY contrast-enhancement solution developed with Bracco, and R&D-stage products including SubtleGAD (gadolinium-dose reduction with Bayer) and SubtleNG (a vision-language foundation model for MRI metadata harmonization).

The company's primary revenue model is SaaS subscription to hospitals and imaging centers, with pricing aligned to scanner deployments across its installed base of 1,300+ scanners and 600+ US sites imaging 2.5 million patients annually. Secondary revenue streams include OEM licensing royalties (notably with Siemens Healthineers) and pharmaceutical industry co-development partnerships (Bracco for AiMIFY, Bayer for SubtleGAD). The go-to-market is enterprise field sales to hospital systems and radiology groups, supplemented by group purchasing contracts (Strategic Radiology, Vizient) and channel partners (Hospiline in Latin America). The company has secured 11 FDA 510(k) clearances, EU MDR CE Marking, Health Canada, ANVISA, and UK MHRA approvals, plus ISO 13485/MDSAP and ISO/IEC 42001 AI Management System certifications, enabling commercial sales across the US, EU, UK, Canada, Brazil, Chile, China (100+ hospitals), and planned APAC expansion. Following a $33 million Series C led by Morgan Stanley Expansion Capital in June 2026, Subtle Medical had raised approximately $86 million in cumulative capital and brought in industry veteran Ohad Arazi (formerly CEO of Zebra Medical Vision and Clarius, and an 11-year McKesson/Change Healthcare executive) as CEO to lead its next phase of global enterprise expansion.

Subtle Medical firmographics

Firmographics
Name
Subtle Medical
Legal name
Subtle Medical, Inc.
Website
https://subtlemedical.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Subtle Medical develops vendor-neutral AI software that enhances MRI, PET, and CT image quality and accelerates scan times, serving hospitals, imaging centers, and OEM partners across 1,300+ scanner deployments worldwide.
Ownership category
akta.pro rank

Subtle Medical industry classification

Industry
Product category
Medical Imaging AI Software
NAICS
Software Publishers (5132), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Medical imaging AI
  • Deep learning radiology
  • MRI image enhancement
  • PET image acceleration
  • AI image denoising

Where Subtle Medical is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Markets served

Subtle Medical business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS Subscription to Hospitals and Imaging Centers: Primary revenue stream - Subtle Medical primarily offers AI solutions as SaaS or software systems to hospitals and imaging centers in the United States, Europe, and Latin America. Recurring subscription model aligned with scanner deployments (over 1,300 scanners worldwide).
  2. OEM Licensing (e.g., Siemens Healthineers): Subtle Medical is contracted by medical imaging equipment manufacturers such as Siemens Healthineers to embed Subtle's AI solutions and platform, providing licensing royalties for workflow, quality, and efficiency enhancements in MRI and PET imaging.
  3. Pharmaceutical Industry Partnerships (Bayer, Bracco): Revenue from co-development agreements with pharmaceutical companies. Bracco's AiMIFY™ is manufactured for Bracco Diagnostics Inc. by Subtle Medical Inc. (OEM/white-label arrangement). Bayer is collaborating on SubtleGAD™ clinical development. These partnerships leverage Subtle's AI solutions for contrast and radiopharmaceutical applications.

Go-to-market motion1 record

Subtle Medical product offering

Product offering

Core offering

Subtle Medical develops vendor-neutral deep learning software that enhances medical image quality and accelerates scan times across MRI, PET, and CT modalities. Its products use convolutional neural networks and generative AI to perform denoising, sharpening, synthetic contrast generation, and automated alignment on existing scanners without requiring new hardware. Solutions are deployed on more than 1,300 scanners worldwide, with the flagship Subtle-ELITE package bundling three FDA-cleared MRI tools.

Product overview

Subtle Medical operates a multi-modality, vendor-neutral AI imaging platform rather than a single unified product, organized around an evolving AI Imaging Hub strategy. The portfolio spans MRI, PET, and CT workflows through distinct AI software products: the Subtle-ELITE package bundles three FDA-cleared MRI tools (SubtleHD(MR) for denoising/sharpening with up to 80% faster scans, SubtleSYNTH for synthetic STIR contrast generation with 100% acceleration, and SubtleALIGN for automated brain MR alignment); standalone products SubtleHD(PET) and SubtleHD(CT) extend the same AI image enhancement paradigm to PET and CT modalities respectively. Legacy products SubtleMR and SubtlePET remain deployed globally, while AiMIFY is a partner-distributed AI contrast enhancement product sold by Bracco. R&D pipeline products include SubtleGAD (reduced gadolinium dose synthesis with Bayer), SubtleREFORMAT (MRI data harmonization), SubtleALLY (workflow automation), and SubtleNG (vision-language foundation model for metadata standardization). Together these products are designed to integrate seamlessly across manufacturer-agnostic scanner fleets, replacing fragmented point solutions with a single AI infrastructure layer for radiology.

Differentiator

Problem solved

Functional benefit

Brands

  • SubtleHD™: AI-powered denoising and sharpening solution for MRI, PET, and CT imaging enhancement, enabling up to 80% faster scan times. Includes SubtleHD(MR), SubtleHD(PET), and SubtleHD(CT) variants.
  • SubtleSYNTH™
  • SubtleALIGN™
  • SubtlePET™
  • SubtleMR™
  • SubtleGAD™
  • Subtle-ELITE™
  • SubtleREFORMAT™
  • SubtleNG™

Products and services

  • Subtle-ELITE Industry-first integrated AI-powered MRI package that combines three FDA-cleared software tools — SubtleHD(MR), SubtleSYNTH, and SubtleALIGN — designed to dramatically improve MRI image quality, reduce scan times, and eliminate manual work through deep learning image processing. Targeted at hospitals and imaging centers.
  • SubtleHD(MR) AI-powered denoising and sharpening software for ultra-clear MRI images, enabling up to 80% faster scan times on some sequences. Vendor-neutral across all body parts, sequences, and contrasts. FDA-cleared and CE-marked. Targeted at radiology departments.
  • SubtleSYNTH AI-generated MR imaging contrasts that synthesize STIR images from existing T1 and T2 weighted sequences with zero additional acquisition time, achieving 100% acceleration. First FDA-cleared AI solution for synthetic imaging. Targeted at MRI imaging centers.
  • SubtleALIGN AI-powered automation of brain MR alignment to ideal anatomical position, reducing manual adjustments and improving consistency across longitudinal studies. Supports 3D brain sequences. Part of the Subtle-ELITE package. Targeted at neuroradiology practices.
  • SubtleHD(PET) AI-powered image enhancement software for low-count PET imaging, denoising PET acquisitions across existing PET, PET/CT, and PET/MR scanners. Enables up to 75% faster PET imaging and supports all FDA-approved radiotracers. Targeted at nuclear medicine and PET centers.
  • SubtleHD(CT) AI-powered denoising software for ultra-clear CT images that reduces noise and improves image clarity across different CT scanner generations. Helps healthcare providers enhance imaging quality from existing CT infrastructure without requiring new hardware. Targeted at radiology departments.
  • SubtleMR First-to-market AI-powered MRI image enhancement software, FDA 510(k) cleared in October 2019, enabling up to 60% faster MRI acquisition. Now superseded by SubtleHD(MR) but still deployed globally on vendor-neutral MRI scanners.
  • SubtlePET First FDA-cleared AI-powered PET image enhancement software, enabling faster, lower-dose PET imaging. Now superseded by SubtleHD(PET) but still deployed across numerous PET scanners worldwide. Targeted at PET imaging centers.
  • AiMIFY AI-powered contrast enhancement software for brain MR images, exclusively developed with Bracco using Subtle Medical technology. Selectively amplifies brain lesion visualization for up to double the visibility of FDA-approved gadolinium doses (GBCAs). FDA-cleared as Class II SaMD. Sold by Bracco as the commercial distributor.
  • SubtleGAD Investigational AI-powered contrast enhancement technology that synthesizes full-dose contrast-enhanced images from reduced gadolinium doses, with research demonstrating potential for up to 90% gadolinium dose reduction while maintaining diagnostic image quality. In active clinical development with Bayer.

Companies that use Subtle Medical

Customer profile

Ideal customer profiles2 records

Subtle Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability9 records

Feature7 records

Subtle Medical partnerships and signals

Strategic signal

Recent moves10 records

Expansion highlights6 records

Subtle Medical competitors and assessment

Company assessment

Direct peers

  • Aidoc: Aidoc provides an AI-powered radiology platform with FDA-cleared algorithms for triage and workflow across CT and MRI. It directly competes with Subtle Medical for enterprise hospital imaging AI contracts and uses a similar SaaS/deployment model across hospital systems.
  • RapidAI: RapidAI offers AI software for neuroimaging and stroke workflow, with FDA-cleared image analysis across MRI and CT. It shares Subtle Medical's hospital-channel enterprise sales motion and vendor-neutral integration model for radiology AI.
  • Viz.ai: Viz.ai develops AI-powered clinical workflow and image analysis for stroke and other time-sensitive conditions, deployed across hospital networks. It competes with Subtle Medical in the same hospital imaging AI category with FDA-cleared products and similar enterprise sales motion.
  • Arterys: Arterys offers a cloud-native AI medical imaging platform with FDA-cleared products for MRI and CT, using deep learning for image quantification and workflow. Its SaaS model, modality focus, and regulatory track record closely mirror Subtle Medical's positioning.
  • Zebra Medical Vision (Nanox): Zebra Medical Vision, now part of Nanox, developed AI imaging algorithms for radiology across multiple modalities and was previously led by Subtle Medical's new CEO Ohad Arazi. It is highly comparable in product strategy and customer base.

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers is both a partner (OEM licensing Subtle's AI) and a competitor through its AI-Rad Companion platform embedded in its MRI and CT scanners. Its installed-base reach and bundled AI strategy represent the largest incumbent threat to Subtle's vendor-neutral model.
  • GE HealthCare: GE HealthCare's Edison AI platform bundles imaging AI directly into its MRI, CT, and PET scanners, competing with Subtle Medical across hospital accounts. Several Subtle Medical executives (CTO, Head of Clinical) are former GE Healthcare leaders, reflecting the close competitive and talent dynamics.
  • Philips: Philips offers AI-enabled imaging solutions across its MRI, CT, and PET/CT installed base and competes broadly with Subtle Medical for hospital imaging AI budget. Subtle Medical's CCO and Head of North America Sales are former Philips executives.
  • Canon Medical Systems (AiCE): Canon Medical's AiCE deep learning reconstruction is embedded in its CT and MRI scanners, directly competing with SubtleHD for acceleration and denoising workloads. As a scanner OEM bundling AI, Canon represents an incumbent channel-conflict risk.

Emerging players

  • United Imaging Intelligence: United Imaging Intelligence develops AI applications across its parent company's MRI, CT, and PET scanner lines, with strong presence in China. It overlaps with Subtle Medical's product portfolio and is a relevant emerging competitor especially across APAC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Subtle Medical social profiles

Digital presence

Subtle Medical compliance and trust

Trust signal

Compliance14 records

Subtle Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Subtle Medical leadership team

Management profile

Number of profiles

Profiles8 records

Subtle Medical funding detail

Funding detail

Funding overview

Funding rounds12 records

Investors25 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Subtle Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Subtle Medical

What does Subtle Medical do?

Subtle Medical develops vendor-neutral deep learning software that enhances medical image quality and accelerates scan times across MRI, PET, and CT modalities. Its products use convolutional neural networks and generative AI to perform denoising, sharpening, synthetic contrast generation, and automated alignment on existing scanners without requiring new hardware. Solutions are deployed on more than 1,300 scanners worldwide, with the flagship Subtle-ELITE package bundling three FDA-cleared MRI tools.

Is Subtle Medical a public or private company?

Subtle Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Subtle Medical founded?

Subtle Medical was founded in 2017. It employs 51 to 100 people.

Where is Subtle Medical based?

Subtle Medical is headquartered in Menlo Park, United States, in the North America region.

How does Subtle Medical make money?

Three revenue lines are on record. SaaS Subscription to Hospitals and Imaging Centers are the primary driver. The others are OEM Licensing (e.g., Siemens Healthineers) and pharmaceutical Industry Partnerships (Bayer, Bracco).

Who are Subtle Medical's main competitors?

Direct peers on record are Aidoc, RapidAI, Viz.ai, Arterys and Zebra Medical Vision (Nanox). Broad incumbents are Siemens Healthineers, GE HealthCare, Philips and Canon Medical Systems (AiCE). United Imaging Intelligence is listed as an emerging player.

Does Subtle Medical have an API?

No public API is recorded for Subtle Medical.

What industry is Subtle Medical in?

Subtle Medical's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Unite.AISubtle Medical Secures Japan Clearance for SubtleHD AI SoftwareSubtle Medical received Japanese marketing certification for SubtleHD AI software on November 18, 2026, enabling hospitals to use it on existing MRI scanners. The software accelerates sequences by up to 80% and integrates with GE, Siemens, Hitachi, and Philips systems. Japan's high MRI density creates a large installed base for the software.PR NewswireSubtle Medical Receives Regulatory Clearance in Japan for SubtleHD™(MR), Expanding Global Access to Faster, Higher-Quality MRISubtle Medical's SubtleHD(MR) software received regulatory certification in Japan under the PMD Act, enabling AI-powered MRI acceleration on existing scanners. The clearance allows up to 80% faster scans with enhanced image quality, addressing Japan's high imaging volumes and limited radiologist workforce. The company will showcase its AI suite at RSNA 2026.Longevity.TechnologyCortechs.ai, Subtle Medical partner to speed MRI measuresCortechs.ai and Subtle Medical announced a strategic partnership on Nov. 10, 2026, to integrate Cortechs.ai's NeuroQuant portfolio with Subtle Medical's MRI enhancement solutions. The partnership combines automated brain volumetry and lesion quantification with AI image enhancement and alignment.PR NewswireCortechs.ai and Subtle Medical Partner to Deliver Faster MRI with Standardized Quantitative NeuroimagingCortechs.ai and Subtle Medical announced a partnership to integrate Cortechs.ai's NeuroQuant neuroimaging portfolio with Subtle Medical's MRI enhancement solutions. The integration aims to support faster imaging protocols and consistent quantitative analysis, with results returned to PACS. The companies will showcase the collaboration at RSNA 2026.PR NewswireSubtle Medical Adds Distribution Partners in the UK and Italy to Support European GrowthSubtle Medical announced distribution agreements with AMG Medtech in the UK and Medical Horizons in Italy to distribute its SubtleHD MR and PET AI software. The software is deployed on over 1,500 scanners worldwide and aims to reduce scan times by up to 80% for MRI and 75% for PET. The partnerships address growing demand and imaging capacity constraints in both regions.PR NewswireSubtle Medical Named to TIME's World's Top HealthTech Companies for the Second Consecutive YearSubtle Medical was named to TIME and Statista's World's Top HealthTech Companies 2026 for the second consecutive year. The company reported revenue growth of over 50% and expanded its AI imaging portfolio across MR, PET, and CT. The recognition underscores its position as a leading innovator in healthcare AI.PR NewswireMedical Image Analysis Software Market worth $6.42 billion by 2031 - Exclusive Report by MarketsandMarkets™The medical image analysis software market is projected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, an 8.1% CAGR. North America held the largest regional share at 38.4% in 2025, and the integrated software segment accounted for 64.5% of the market. AI-enabled technology is expected to see the fastest growth at 8.6% CAGR.Imaging Technology NewsSubtle Medical Appoints Executive Medical DirectorSubtle Medical appointed Lawrence N. Tanenbaum, MD, FACR, as Executive Medical Director and Chair of its Medical Advisory Board. The appointment expands his role as an advisor since 2019, supporting AI-powered imaging across MRI, PET, and CT. He will guide clinical strategy and product development.AuntMinnieSubtle Medical names Tanenbaum executive medical directorSubtle Medical named Lawrence Tanenbaum, MD, as executive medical director and chair of its Medical Advisory Board. He previously served as vice president, chief technology officer, and director of advanced imaging at RadNet, where he helped deploy SubtleMR AI-powered MRI software. He will guide clinical strategy and product development across Subtle Medical's AI imaging platform.PR NewswireRenowned radiology innovator and longtime Subtle Medical advisor expands role to help advance the company's next generation of AI-powered imaging solutionsSubtle Medical appointed Lawrence N. Tanenbaum, MD, as Executive Medical Director and Chair of its Medical Advisory Board to expand his role in advancing AI-powered imaging solutions. This appointment builds on Dr. Tanenbaum's advisory relationship with the company since 2019 and aims to strengthen Subtle Medical's clinical strategy and product development across MRI, PET, and CT platforms.